By progressing from a lower dose to a higher one, patients can achieve optimal glycemic control while minimizing the risk of adverse reactions
Diagnostic Testing Your journey begins with advanced diagnostic testing that goes beyond a routine exam
Semaglutides 1015% average weight reduction is well-documented across multiple large-scale trials and represents an established benchmark for GLP-1-based weight loss therapy
These two systems simply operate under different oversight structures, so medical providers help determine which route best fits a patients needs, access, and overall health plan
Yes, switching from Semaglutide (Ozempic, Wegovy) to Tirzepatide (Mounjaro, Zepbound) is possible, but it depends on several factors, including your medical history, response to treatment, and availability